ATE214692T1 - Metalloproteinase-inhibitoren - Google Patents
Metalloproteinase-inhibitorenInfo
- Publication number
- ATE214692T1 ATE214692T1 AT97947158T AT97947158T ATE214692T1 AT E214692 T1 ATE214692 T1 AT E214692T1 AT 97947158 T AT97947158 T AT 97947158T AT 97947158 T AT97947158 T AT 97947158T AT E214692 T1 ATE214692 T1 AT E214692T1
- Authority
- AT
- Austria
- Prior art keywords
- metalloproteinase inhibitors
- inhibitors
- conhoh
- cooh
- compound
- Prior art date
Links
- 239000003475 metalloproteinase inhibitor Substances 0.000 title 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000008354 tissue degradation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9625154.1A GB9625154D0 (en) | 1996-12-04 | 1996-12-04 | Metalloproteinase inhibitors |
| GBGB9713472.0A GB9713472D0 (en) | 1997-06-27 | 1997-06-27 | Metalloproteinase inhibitors |
| PCT/GB1997/003316 WO1998024759A1 (en) | 1996-12-04 | 1997-12-02 | Metalloproteinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214692T1 true ATE214692T1 (de) | 2002-04-15 |
Family
ID=26310541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97947158T ATE214692T1 (de) | 1996-12-04 | 1997-12-02 | Metalloproteinase-inhibitoren |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5840974A (de) |
| EP (1) | EP0944587B1 (de) |
| JP (1) | JP2001508047A (de) |
| AT (1) | ATE214692T1 (de) |
| AU (1) | AU5230898A (de) |
| DE (1) | DE69711221D1 (de) |
| WO (1) | WO1998024759A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710490D0 (en) * | 1997-05-21 | 1997-07-16 | British Biotech Pharm | Metalloproteinase inhibitors |
| PT1047665E (pt) * | 1998-01-09 | 2004-01-30 | Pfizer | Inibidores de metaloproteases de matriz |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| KR20090088857A (ko) * | 2006-09-12 | 2009-08-20 | 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 | 아세틸렌 화합물 |
| JP5727228B2 (ja) * | 2007-12-20 | 2015-06-03 | ファルマ・マール・ソシエダード・アノニマ | 抗腫瘍化合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
| US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
| ATE169621T1 (de) * | 1993-03-16 | 1998-08-15 | British Biotech Pharm | Hydroxamsaeurederivate als metalloproteinase inhibitoren |
| JPH09503492A (ja) * | 1993-08-02 | 1997-04-08 | セルテック・セラピューティクス・リミテッド | スクシンアミド誘導体、それらの調製法及びそれらのゼラチナーゼ及びコラゲナーゼ阻害剤としての使用 |
| US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
| BR9506535A (pt) * | 1994-01-20 | 1997-09-16 | British Biotech Pharm | Inibidores de metaloproteinases |
| GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
| GB9411598D0 (en) * | 1994-06-09 | 1994-08-03 | Hoffmann La Roche | Hydroxamic acid derivatives |
| GB9416897D0 (en) * | 1994-08-20 | 1994-10-12 | British Biotech Pharm | Metalloproteinase inhibitors |
| GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
| GB9504084D0 (en) * | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
| GB9507799D0 (en) * | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
| GB9513331D0 (en) * | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
-
1997
- 1997-09-08 US US08/925,592 patent/US5840974A/en not_active Expired - Fee Related
- 1997-12-02 AT AT97947158T patent/ATE214692T1/de active
- 1997-12-02 JP JP52533998A patent/JP2001508047A/ja active Pending
- 1997-12-02 AU AU52308/98A patent/AU5230898A/en not_active Abandoned
- 1997-12-02 DE DE69711221T patent/DE69711221D1/de not_active Expired - Lifetime
- 1997-12-02 EP EP97947158A patent/EP0944587B1/de not_active Expired - Lifetime
- 1997-12-02 WO PCT/GB1997/003316 patent/WO1998024759A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998024759A1 (en) | 1998-06-11 |
| EP0944587B1 (de) | 2002-03-20 |
| US5840974A (en) | 1998-11-24 |
| JP2001508047A (ja) | 2001-06-19 |
| AU5230898A (en) | 1998-06-29 |
| EP0944587A1 (de) | 1999-09-29 |
| DE69711221D1 (de) | 2002-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700557A (es) | Dihidrobenzofuranos. | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| DE69620443D1 (de) | Naphthyl substituierte benzimidazolderivate als antikoagulantien | |
| TR199901653T2 (xx) | Fitalazinonlar. | |
| TR200100605T2 (tr) | Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı | |
| ATE205187T1 (de) | Metalloproteinase hemmende verbindungen | |
| KR950700894A (ko) | 탁솔 유도체(Taxol derivatives) | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| TR199802536T2 (xx) | Yeni amino asit t�revleri,trombin inhibit�rleri olarak kullan�lmalar�. | |
| NO20024745D0 (no) | 2-hydroksymutilinkarbamat-derivater for antibakteriell anvendelse | |
| DE69812634D1 (de) | Metalloproteinase-inhibitoren | |
| DK0696278T3 (da) | Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| TR200003859T2 (tr) | Amidino ve guanidino azetidinon triptaz önleyicileri | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| ATE320422T1 (de) | Metalloproteinase inhibitoren | |
| ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
| DE69711221D1 (de) | Metalloproteinase-inhibitoren | |
| ATE223226T1 (de) | Azazyklohexapeptid-verbindungen | |
| TR200100133T2 (tr) | FKBP İnhibitörleri | |
| DK0775113T3 (da) | N-substituerede azabicycloheptan-derivater som neuroleptika osv. | |
| DK0683777T3 (da) | Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler | |
| DK0668852T3 (da) | Substituerede orthoethenylphenyleddikesyrederivater | |
| TR200001122T2 (tr) | Farmasötikler olarak bifenil türevleri. | |
| ATE238781T1 (de) | Verwendung von katecholderivaten als proteinaseinhibitoren |